De Luca A - Search Results

1

Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.

Murri R, Ammassari A, Trotta MP, De Luca A, Melzi S, Minardi C, Zaccarelli M, Rellecati P, Santopadre P, Soscia F, Scasso A, Tozzi V, Ciardi M, Orofino GC, Noto P, Monforte Ad, Antinori A, Wu AW; AdICoNa Study Group. Murri R, et al. Among authors: de luca a. J Gen Intern Med. 2004 Nov;19(11):1104-10. doi: 10.1111/j.1525-1497.2004.30248.x. J Gen Intern Med. 2004. PMID: 15566439 Free PMC article.

2

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

Cingolani A, Antinori A, Rizzo MG, Murri R, Ammassari A, Baldini F, Di Giambenedetto S, Cauda R, De Luca A. Cingolani A, et al. Among authors: de luca a. AIDS. 2002 Feb 15;16(3):369-79. doi: 10.1097/00002030-200202150-00008. AIDS. 2002. PMID: 11834948 Clinical Trial.

3

Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia.

Sorà F, Antinori A, Piccirillo N, De Luca A, Chiusolo P, Cingolani A, Laurenti L, Rutella S, Ortona L, Leone G, Sica S. Sorà F, et al. Among authors: de luca a. Exp Hematol. 2002 Mar;30(3):279-84. doi: 10.1016/s0301-472x(01)00793-7. Exp Hematol. 2002. PMID: 11882366 Free article.

4

Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy.

Gillini LA, Cingolani A, Murri R, De Luca A, Di Giambenedetto S, Wu A, Cauda R, Chaisson RE. Gillini LA, et al. Among authors: de luca a. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):546-7. doi: 10.1097/00126334-200204150-00018. J Acquir Immune Defic Syndr. 2002. PMID: 11981374 No abstract available.

5

Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals.

De Luca A, Ciancio BC, Larussa D, Murri R, Cingolani A, Rizzo MG, Giancola ML, Ammassari A, Ortona L. De Luca A, et al. Neurology. 2002 Aug 13;59(3):342-7. doi: 10.1212/wnl.59.3.342. Neurology. 2002. PMID: 12177366

6

Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure.

Antinori A, Zaccarelli M, Cingolani A, Forbici F, Rizzo MG, Trotta MP, Di Giambenedetto S, Narciso P, Ammassari A, Girardi E, De Luca A, Perno CF. Antinori A, et al. Among authors: de luca a. AIDS Res Hum Retroviruses. 2002 Aug 10;18(12):835-8. doi: 10.1089/08892220260190308. AIDS Res Hum Retroviruses. 2002. PMID: 12201905

7

A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.

Van Laethem K, De Luca A, Antinori A, Cingolani A, Perna CF, Vandamme AM. Van Laethem K, et al. Among authors: de luca a. Antivir Ther. 2002 Jun;7(2):123-9. Antivir Ther. 2002. PMID: 12212924

8

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group. De Luca A, et al. Arch Intern Med. 2002 Oct 14;162(18):2125-32. doi: 10.1001/archinte.162.18.2125. Arch Intern Med. 2002. PMID: 12374521

9

Virologic correlates of adherence to antiretroviral medications and therapeutic failure.

Perno CF, Ceccherini-Silberstein F, De Luca A, Cozzi-Lepri A, Gori C, Cingolani A, Bellocchi MC, Trotta MP, Piano P, Forbici F, Scasso A, Vullo V, d'Arminio Monforte A, Antinori A; AdICoNA Study Group. Perno CF, et al. Among authors: de luca a. J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S118-22. doi: 10.1097/00126334-200212153-00006. J Acquir Immune Defic Syndr. 2002. PMID: 12562033 Review.

10

Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group.

Mussini C, Pezzotti P, Antinori A, Borghi V, Monforte Ad, Govoni A, De Luca A, Ammassari A, Mongiardo N, Cerri MC, Bedini A, Beltrami C, Ursitti MA, Bini T, Cossarizza A, Esposito R; Changes in Opportunistic Prophylaxis (CIOP) Study Group. Mussini C, et al. Among authors: de luca a. Clin Infect Dis. 2003 Mar 1;36(5):645-51. doi: 10.1086/367659. Epub 2003 Feb 12. Clin Infect Dis. 2003. PMID: 12594647 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,252 results

Search Page

Filters